| Financial Year |
March 31 2023 |
| Monetary Funds |
4,688,452,493.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
5,043,966,707.52 |
| Advances to Suppliers |
416,231,409.36 |
| Other Receivables |
134,995,372.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
90,494,012.69 |
| Inventories |
2,440,513.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
416,119,192.45 |
| Total Current Assets |
10,789,449,758.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
538,581,214.09 |
| Investment Properties |
-- |
| Fixed Assetes |
20,033,481,143.81 |
| Under-construction Projects |
3,320,815,721.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,824,476.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,488,069.23 |
| Deferred Income Tax Assets |
42,036,154.81 |
| Other Non-Current Assets |
1,687,350,408.85 |
| Sub-Total of Non-Current Assets |
26,862,474,973.52 |
| Total Assets |
37,651,924,731.66 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,500,000.00 |
| Accounts Payable |
1,297,452,258.04 |
| Accounts Received In Advance |
4,671,765.68 |
| Employee Compensation Payable |
5,676,842.18 |
| Taxes Payable |
66,645,075.21 |
| Interest Payable |
-- |
| Dividend Payable |
59,679,654.27 |
| Other payables |
140,488,864.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,019,307,800.52 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,538,043,277.34 |
| Long-term Loans |
14,445,684,699.41 |
| Bonds Payable |
998,335,379.44 |
| Long-Term Accounts Payable |
1,100,061,566.19 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
631,041.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,157,927,949.39 |
| Total Liabilities |
19,695,971,226.73 |
| Paid-In Capital(Or Share Stock) |
1,862,520,720.00 |
| Capital Surplus |
4,476,616,506.36 |
| Surplus Reserve |
931,260,360.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,392,419,355.69 |
| Minority Stockholder's Interest |
1,302,887,515.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,653,065,989.54 |
| Owner's Equity（Stockholder's Equity） |
17,955,953,504.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,651,924,731.66 |
